Discover how deep learning technologies revolutionize breast cancer screening, efficiently identifying false positives while ensuring the detection of true cancer cases. Through rigorous evaluation and validation, these AI-driven tools demonstrate significant reductions in unnecessary…
Continue Reading
By Shania Kennedy
April 12, 2024 – Researchers have developed a deep learning tool capable of reducing false positives without missing true cases of breast cancer identified by screening mammography, according to a study published this…
Continue Reading
South Korean medical AI company Lunit has recently secured deals with hospitals in Europe, where the medical device market – the second largest after the North American market – is worth $155 billion.It won the contract to supply…
Continue Reading
Karen Grinzaid, Assistant Professor of Human Genetics and Executive Director of JScreen, a national online genetic disease screening program based out of Emory University School of Medicine again joins eHealth Radio and the Health…
Continue Reading
What You Should Know:
– Lunit (KRX:328130.KQ), a provider of AI-powered cancer diagnostics and therapeutics solutions, announced today two significant commercial agreements that mark its continued European expansion.
– These strategic deals will bring Lunit’s AI-powered…
Continue Reading
Gleneagles Hospital, part of the international private hospital group IHH Healthcare, has partnered with medical AI providers to bolster its diagnostics capability in Singapore and Hong Kong. On one hand, the radiology department at Gleneagles Hong…
Continue Reading
Discover how Transpara Breast AI by ScreenPoint Medical revolutionizes mammography screening by providing radiologists with advanced support in cancer detection. Through real-world clinical studies presented at the European Congress of Radiology, learn how Transpara…
Continue Reading
Effective breast cancer screening is vital in reducing mortality rates among women. This study explores the optimal age to commence screening and the frequency for maximum benefits. By analyzing data from the Cancer Intervention…
Continue Reading
Hologic’s Genius Digital Diagnostics System, empowered by the Genius Cervical AI algorithm, has received FDA approval, marking a significant advancement in cancer screening technology. This innovative system integrates deep learning AI with advanced imaging…
Continue Reading
Medical technology firm Hologic has been granted clearance from the FDA to market its Genius Digital Diagnostics System, powered by the company’s Genius Cervical AI algorithm.The digital cytology system–a medical diagnostic tool used to…
Continue Reading
